Subject: Relevance of ARNi, Carvedilol, Ivabradine in Indian Heart Failure patients to Strengthen the Evidence based practice
Heart Failure is one of the most common reasons people aged 65 and older go into the hospital. Heart failure is a serious long-term (chronic) condition. But one
can live a full, active life with the right medical treatment and attention to a proper lifestyle.
Pharmacological treatments of HF include Angiotensin Receptor Neprilysin inhibitors (ARNi), angiotensin
receptor blockers (ARBs), beta-blockers, diuretics, aldosterone antagonists hydralazine/nitrates, and
digoxin. Carvedilol is a non-selective adrenergic blocker indicated for the chronic therapy of heart failure.
Ivabradine has undergone "fast track" evaluation to reduce the risk of hospitalization for worsening HF in
patients with stable, symptomatic chronic HF. Non-Vitamin k anticoagulants (NOACs) like Dabigatran are
used to decrease the risk of stroke and blood clots in patients with serious heart rhythm problems. This
questionnaire attempts to find out the current trends in the management of heart failure.
|
}}){kind=logo}
}})